7 Top Stocks to Buy for Under $10: May 2024
It’s always a good idea to fortify your portfolio with blue-chip stocks – solid, dependable names that you can bank on to deliver each quarter. But you can’t stop there. In order to diversify yo...
- Supported exchanges /
- NASDAQ /
- ELEV.NASDAQ
Elevation Oncology Inc (ELEV NASDAQ) stock market data APIs
$0.5956
0.01(1.7%)
as of September 20, 2024
Price chart is built with Anychart
Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. The company's lead candidate is EO-3021, an antibody-drug conjugate designed to target Claudin 18.2, a clinically validated molecular target. Its EO-3021 selectively delivers a cytotoxic payload directly to cancer cells expressing Claudin 18.2. Elevation Oncology, Inc. has a license agreement with CSPC Megalith Biopharmaceutical Co., Ltd. to develop and commercialize EO-3021. The company was formerly known as 14ner Oncology, Inc. and changed its name to Elevation Oncology, Inc. in February 2020. The company was incorporated in 2019 and is based in Boston, Massachusetts.
Elevation Oncology Inc Financial Data Overview
| 0.5859 | |
| 0.5956 | |
| - | |
| 0.6185 | |
| 0.58 | |
| 0.363-5.8299 | |
| 35 452 K | |
| 59 107 K | |
| 0 | |
| -0.18 | |
| 1.272 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'ELEV',
Type:
'Common Stock',
Name:
'Elevation Oncology Inc',
Exchange:
'NASDAQ',
CurrencyCode:
'USD',
CurrencyName:
'US Dollar',
CurrencySymbol:
'$',
CountryName:
'USA',
CountryISO:
'US',
OpenFigi:
'BBG00W7CX151',
ISIN:
NULL,
CUSIP:
NULL,
CIK:
'1783032',
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
'2021-06-25',
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
HomeCategory:
NULL,
IsDelisted:
false,
}
Elevation Oncology Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -39 665 000
- Earnings Per Share -0.68
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Elevation Oncology Inc Earnings via APIs
- Latest Release 2024-08-06
- EPS/Forecast -0.22
Get Elevation Oncology Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Elevation Oncology Inc latest news via APIs
13 Hot Stocks to Invest in According to Wall Street Analysts
In this piece, we will take a look at the 13 hot stocks to invest in according to Wall Street analysts. If you want to skip our overview of the stock market and the latest news, then you can skip ahea...
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
